Fecal transplant study for people with Crohn’s disease
Treatments studied
Part of Digestive system clinical trials.
This study tests whether a standardized stool-based treatment (fecal microbiota transplantation) can help people with Crohn’s disease. You may qualify if your Crohn’s diagnosis has been stable and you’re willing to receive the fecal transplant.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a confirmed Crohn’s disease diagnosis that has not changed after at least 3 months of follow-up
- You are willing to receive fecal microbiota transplantation (a stool-based treatment using processed donor material)
- You do not have serious illnesses that would make the study unsafe for you (for example, certain cancers)
- You should not have serious heart or lung problems or severe breathing/circulation failure
- You should not have severe liver or kidney disease
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 1 study tests whether transferring healthy gut bacteria (a fecal microbiome transplant) can help children with repeated or moderate-to-severe C. difficile infection. It focuses on changing gut bacteria to reduce ongoing infection and symptoms.
This trial tests whether transferring stool microbes (called fecal microbiota transplantation, or FMT) can improve Crohn’s disease in children who have not gotten better with usual treatments. If you qualify, the study will check symptoms and colon imaging/score changes over the study follow-up.
This trial tests whether a fecal transplant (putting healthy bacteria into your gut) combined with dietary changes can help control active Crohn's disease. It is for people who need stronger treatments or have stopped responding to their current therapy.
This Phase 1/2 study tests whether a fecal microbiome transplant (FMT) can reduce active inflammation in people with Crohn’s disease. It’s designed for people who currently have signs of active bowel inflammation and can attend regular procedure visits.
This study tests whether a combination of fecal transplant (transferring healthy bacteria from a donor) and dietary changes can help control disease activity in people newly diagnosed with Crohn's. It is for those with mild to moderate symptoms who have not yet taken any Crohn's medications.
This trial studies fecal microbiota transplantation (a transplant of beneficial gut bacteria from a donor) to help people with Crohn’s disease that is causing narrowing (strictures) and/or abnormal tunnels (fistulas) and who need bowel surgery. You may qualify if you’re an adult, planning ileal/ileocecal surgery, and can complete the colonoscopy while not on certain gut-altering medicines.
Hear when a new Inflammatory Bowel Diseases trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.